A Pharmacoepidemiological Approach to Evaluate Drug-Drug Interactions in a Specialized Stroke Unit in Pakistan

被引:0
|
作者
Shakeel, Faisal [1 ]
Khan, Jamshaid A. [2 ]
Aamir, Muhammad [2 ]
机构
[1] Sarhad Univ Sci & IT, Dept Pharm, Peshawar, Pakistan
[2] Univ Peshawar, Dept Pharm, Peshawar, Pakistan
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2018年 / 37卷 / 09期
关键词
clinical pharmacy; drug-drug interactions; stroke; GLOBAL BURDEN; RISK-FACTORS; PREVALENCE; EPIDEMIOLOGY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Stroke is one of the common diseases responsible for morbidity and mortality worldwide, despite advancements in its treatment and management through drug therapy or surgical intervention. Drug interactions in stroke patients present a unique challenge as the patient's critical condition makes concomitant drug administration risky. The aim was to determine the prevalence of potential drug-drug interactions, and to identify clinically significant drug-drug interactions. The cross sectional one-year study was carried out in a stroke unit of a tertiary care hospital. Patient medication charts were evaluated for potential drug-drug interactions using Micromedex DrugReax. Statistical analysis was carried out using IBM SPSS Statistics for Windows. A 70.8% prevalence of potential drug-drug interactions was observed in the patients of stroke unit. Clinically significant interactions were present in 58.2% patients which was attributed to 58 drug pairs. A significant association was present between number of interactions and number of prescribed drugs and age.
引用
收藏
页码:1882 / 1887
页数:6
相关论文
共 50 条
  • [21] Screening for clinically relevant drug-drug interactions between direct oral anticoagulants and antineoplastic agents: a pharmacovigilance approach
    Truong, Bang
    Hornsby, Lori
    Fox, Brent I.
    Chou, Chiahung
    Zheng, Jingyi
    Qian, Jingjing
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (04) : 555 - 567
  • [22] Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments
    Fokter, Nina
    Mozina, Martin
    Brvar, Miran
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (3-4) : 81 - 88
  • [23] Clinically important drug-drug interactions in primary care
    Dhabali, A. A. H.
    Awang, R.
    Zyoud, S. H.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (04) : 426 - 430
  • [24] Characterization of potential drug-drug interactions in patients hospitalized in the intensive care unit of a tertiary hospital in Bogota
    Hernandez, Marcela
    Tribino, Gabriel
    Bustamante, Carlos
    BIOMEDICA, 2018, 38 (03): : 407 - 416
  • [25] Macrolide Treatment Failure due to Drug-Drug Interactions: Real-World Evidence to Evaluate a Pharmacological Hypothesis
    Cicali, Brian
    Schmidt, Stephan
    Zeitlinger, Markus
    Brown, Joshua D.
    PHARMACEUTICS, 2022, 14 (04)
  • [26] Medication control in hospitals: a practical approach to the problem of drug-drug interactions
    Wiltink, EH
    PHARMACY WORLD & SCIENCE, 1998, 20 (04): : 173 - 177
  • [27] Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions
    Magro, Lara
    Moretti, Ugo
    Leone, Roberto
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (01) : 83 - 94
  • [28] Anti hypertensive drug-drug interactions
    Morales-Olivas, FJ
    Estañ, L
    MEDICINA CLINICA, 2005, 124 (20): : 782 - 789
  • [29] A Review of Daclatasvir Drug-Drug Interactions
    Garimella, Tushar
    You, Xiaoli
    Wang, Reena
    Huang, Shu-Pang
    Kandoussi, Hamza
    Bifano, Marc
    Bertz, Richard
    Eley, Timothy
    ADVANCES IN THERAPY, 2016, 33 (11) : 1867 - 1884
  • [30] Drug-Drug Interactions: How to Manage the Risk-A Stakeholder Approach
    Beninger, Paul
    CLINICAL THERAPEUTICS, 2023, 45 (02) : 106 - 116